Scholarlink

Introduction <p>Essential tremor is a common movement disorder that can cause substantial functional disability when symptoms become medically refractory. Stereotactic radiosurgery (SRS) is a minimal access treatment strategy for tremor control, but multicenter outcome data remain limited.</p> Methods <p>We performed a retrospective multi-institutional cohort study of 232 stereotactic radiosurgical thalamotomy procedures for medically refractory essential tremor. The median age at treatment was 76.0&#xa0;years, median tremor duration was 17.0&#xa0;years, median margin dose was 70.0&#xa0;Gy, and median maximum dose was 140.0&#xa0;Gy. The primary endpoint was clinically meaningful tremor improvement. Secondary endpoints included tremor arrest, recurrence, adverse radiation effects (AREs), and change in Fahn–Tolosa–Marín (FTM) scores. Logistic regression was used to evaluate outcome predictors.</p> Results <p>Significant tremor improvement was observed in 92.1% of patients, with a median time to improvement of 4.0&#xa0;months. Complete tremor relief occurred in 26.1%. Symptomatic AREs occurred in 4.3%. Tremor recurrence was noted in 12.4% at median follow-up of 2&#xa0;years. Among procedures, mean unilateral hand FTM score improved from 12.53 to 5.07, corresponding to a mean improvement of 7.46 points (<i>p</i> &lt; 0.001). Significant improvement was also observed across tremor, writing, drawing, and drinking sub scores (all <i>p</i> &lt; 0.001). On multivariable analysis, a maximum lesion dose ≥ 140&#xa0;Gy was independently associated with greater odds of clinical benefit (OR 3.44, <i>p</i> = 0.019).</p> Conclusion <p>In this multi-institutional cohort, SRS was associated with high rates of clinically meaningful tremor improvement, significant functional improvement, and durable tremor control in medically refractory essential tremor.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Role of radiosurgical thalamotomy in the management for essential tremor: evidence from an international multi-institutional study

  • 期刊论文

  • 发表日期：

    2026年6月16日

查看全文
  • Ajay Niranjan,
  • Jheremy S. Reyes,
  • Constantinos G. Hadjipanayis,
  • Daniel M. Trifiletti,
  • Samir Patel,
  • Kenneth Bernstein,
  • Eliane Di Battista,
  • Christian Iorio-Morin,
  • Shayan Moosa,
  • Yavuz Samanci,
  • Manjul Tripathi,
  • David Mathieu,
  • Selcuk Peker,
  • Jason P. Sheehan,
  • Douglas Kondziolka,
  • Lawrence Dade Lunsford

摘要

Introduction

Essential tremor is a common movement disorder that can cause substantial functional disability when symptoms become medically refractory. Stereotactic radiosurgery (SRS) is a minimal access treatment strategy for tremor control, but multicenter outcome data remain limited.

Methods

We performed a retrospective multi-institutional cohort study of 232 stereotactic radiosurgical thalamotomy procedures for medically refractory essential tremor. The median age at treatment was 76.0 years, median tremor duration was 17.0 years, median margin dose was 70.0 Gy, and median maximum dose was 140.0 Gy. The primary endpoint was clinically meaningful tremor improvement. Secondary endpoints included tremor arrest, recurrence, adverse radiation effects (AREs), and change in Fahn–Tolosa–Marín (FTM) scores. Logistic regression was used to evaluate outcome predictors.

Results

Significant tremor improvement was observed in 92.1% of patients, with a median time to improvement of 4.0 months. Complete tremor relief occurred in 26.1%. Symptomatic AREs occurred in 4.3%. Tremor recurrence was noted in 12.4% at median follow-up of 2 years. Among procedures, mean unilateral hand FTM score improved from 12.53 to 5.07, corresponding to a mean improvement of 7.46 points (p < 0.001). Significant improvement was also observed across tremor, writing, drawing, and drinking sub scores (all p < 0.001). On multivariable analysis, a maximum lesion dose ≥ 140 Gy was independently associated with greater odds of clinical benefit (OR 3.44, p = 0.019).

Conclusion

In this multi-institutional cohort, SRS was associated with high rates of clinically meaningful tremor improvement, significant functional improvement, and durable tremor control in medically refractory essential tremor.